Validation of an Objective Instrument to Measure Hot Flashes During Menopause
Status: | Recruiting |
---|---|
Conditions: | Hot Flash, Women's Studies |
Therapuetic Areas: | Reproductive |
Healthy: | No |
Age Range: | 45 - 60 |
Updated: | 9/13/2018 |
Start Date: | September 7, 2018 |
End Date: | December 31, 2019 |
Contact: | Kara L Marlatt, PhD, MPH |
Email: | kara.marlatt@pbrc.edu |
Phone: | 225-763-2871 |
The overarching aim of this study is to assess the validity of the iButton®, a dual
temperature and humidity sensing device (DS1923; Maxim IntegratedTM), as an objective method
to assess hot flash incidence and dynamics in both a real world (ambulatory) and controlled
(laboratory) setting. This study will test the overarching hypothesis that both self-report
hot flashes in both an ambulatory and laboratory setting will correlate (confirm) the
temperature and humidity sensing observed via the iButton® technology.
temperature and humidity sensing device (DS1923; Maxim IntegratedTM), as an objective method
to assess hot flash incidence and dynamics in both a real world (ambulatory) and controlled
(laboratory) setting. This study will test the overarching hypothesis that both self-report
hot flashes in both an ambulatory and laboratory setting will correlate (confirm) the
temperature and humidity sensing observed via the iButton® technology.
Using iButton® technology as an objective instrument to measure hot flash dynamics, the
investigators will validate the technology in 12 perimenopausal women ages 45-60 y and BMI
18.5-40 kg/m2 who experience greater than or equal to 4 hot flashes per day. First, the
investigators will validate the iButton® technology against self-report (subjective) hot
flash incidence in a real world, ambulatory condition (via a hot flash journal). Next, the
investigators will validate the iButton® technology during a controlled,
laboratory-stimulated hot flash using a tube-lined suit that circulates warm water uniformly
around the lower limbs (Med-EngTM). During the stimulated hot flash, the investigators will
simultaneously measure core body temperature, skin blood flow, skin temperature, sweat rate,
and heart rate alongside the iButton® to correlate (confirm) the observed thermoregulatory
changes and further assess validity. To date, existing studies using iButtons® to assess
changes in skin temperature have been conducted.
Each subject will undergo a two-phased screening to determine eligibility. Pre-enrollment
measurements will include standard anthropometrics (weight, height), vital signs (blood
pressure, heart rate), fasting blood draw, and questionnaires, as well as a 7-day hot flash
journal that captures frequency and severity screening. Post-enrollment measurements will
include simultaneous objective (via iButtons®) and subjective (via self-report journal) hot
flash recordings (i.e., field testing), as well as a final laboratory visit will be conducted
at Louisiana State University's School of Kinesiology and include body composition
assessment, as well as the following assessments during a stimulated hot flash -- core
temperature, skin blood flow, skin temperature, sweat rate, and heart rate.
investigators will validate the technology in 12 perimenopausal women ages 45-60 y and BMI
18.5-40 kg/m2 who experience greater than or equal to 4 hot flashes per day. First, the
investigators will validate the iButton® technology against self-report (subjective) hot
flash incidence in a real world, ambulatory condition (via a hot flash journal). Next, the
investigators will validate the iButton® technology during a controlled,
laboratory-stimulated hot flash using a tube-lined suit that circulates warm water uniformly
around the lower limbs (Med-EngTM). During the stimulated hot flash, the investigators will
simultaneously measure core body temperature, skin blood flow, skin temperature, sweat rate,
and heart rate alongside the iButton® to correlate (confirm) the observed thermoregulatory
changes and further assess validity. To date, existing studies using iButtons® to assess
changes in skin temperature have been conducted.
Each subject will undergo a two-phased screening to determine eligibility. Pre-enrollment
measurements will include standard anthropometrics (weight, height), vital signs (blood
pressure, heart rate), fasting blood draw, and questionnaires, as well as a 7-day hot flash
journal that captures frequency and severity screening. Post-enrollment measurements will
include simultaneous objective (via iButtons®) and subjective (via self-report journal) hot
flash recordings (i.e., field testing), as well as a final laboratory visit will be conducted
at Louisiana State University's School of Kinesiology and include body composition
assessment, as well as the following assessments during a stimulated hot flash -- core
temperature, skin blood flow, skin temperature, sweat rate, and heart rate.
Inclusion Criteria:
- Healthy female
- Ages 45-60 y
- BMI between 18.5 kg/m2 and 40 kg/m2 (inclusive)
- Self-reported ≥4 hot flashes per day (for 4 out of the 7 days) (via 7-d hot flash
journal)
- Meets both criteria for "peri-menopause (late phase)" classification: (1) experiences
menopause-related symptoms (including hot flashes); (2) has hot gone 12 months in a
row without a menstrual cycle; however, has sometimes more than 60 days between
cycles.
- Medically cleared for participation by the Medical Investigator
Exclusion Criteria:
- Current smokers, or having smoked within the last 3 months
- History of diabetes (or other metabolic diseases)
- History of neurological disease
- History of cardiovascular disease
- Taking hormone replacement therapy, or other therapies/supplements designed to reduce
severity of menopause symptoms (e.g., hot flashes)
- Pregnant, planning to become pregnant, or currently breastfeeding
We found this trial at
1
site
Pennington Biomedical Research Center Unlike other medical research facilities where science occurs in separate labs...
Click here to add this to my saved trials
